Charles River Laboratories

CRL pushes deeper into an increasingly lucrative Asia

Charles River expands presence in Asia with acquisition

By Zachary Brennan

Early stage drug developer Charles River Laboratories is pushing further into Asia with its purchase of the microbiology subcontractor BRASS Pte Ltd. Terms of the acquisition were not disclosed.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers